Background: Several studies carried out in the USA and in Europe have shown the
presence of HTLV-I/II antibodies in subjects belonging to high-risk groups for HIV infection …

Human T lymphotropic viruses (HTLVs) have a limited spread in the general populations of
Western countries. Consequently, the transfusional risk for HTLV is considered to be low in …

Published and unpublished data on the HTLV-I seroprevalence in 13 European countries
(sample a total of 79.549 persons) was subject to meta-analysis. HTLV-I infection was …

The seroprevalence of HTLV-I/II was evaluated in 1247 Italian individuals at high risk for HIV
infection. The population studied consisted of 985 intravenous drug users (IVDUs), 474 of …

A seroepidemiological survey has been carried out in the Veneto region to determine the
prevalence of HTLV-III and HTLV-I antibodies in subjects at risk for development of AIDS …

Human T-lymphotropic virus type I (HTLV-I) infects an estimated 15–20 million persons
worldwide. A number of diseases have been associated with the virus including adult T-cell …

A preliminary survey of the prevalence of HTLV-I antibody during 1987 and 1988 in Belgium
revealed no positive results among selected blood donors who sided for some length of time …

In the present study, we evaluated the seroprevalence of HTLV-I/II infection among the blood
donors in Santa Fe and Santiago del Estero provinces. A total of 1327 serum samples from …

Soriano et al.[1] showed that HTLV-I and HTLV-II are both present in Spain and that HTLV-I
is still mainly associated with indi viduals visiting or born in endemic areas and HTLV-II with …

BACKGROUND: In addition to human immunodeficiency virus, human T‐lymphotropic virus
types I and II (HTLV‐I/II) is prevalent among blood donors in the United States. In Greece …